Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum‐based chemotherapy
Emilie C. H. Breekveldt(Erasmus MC), Monique E. van Leerdam(Leiden University Medical Center), William Hisey(Dartmouth–Hitchcock Medical Center), Michael Schaapveld(The Netherlands Cancer Institute), Sasja F. Mulder(Radboud University Nijmegen), Lynn F. Butterly(Dartmouth–Hitchcock Medical Center), Lisette J. Saveur(The Netherlands Cancer Institute), Leon M.G. Moons(University Medical Center Utrecht), Manon C.W. Spaander(Erasmus University Rotterdam), Flora E. van Leeuwen(The Netherlands Cancer Institute), Agnes N. Reijm(Erasmus MC), Dorien T. J. van der Biessen‐van Beek(Radboud University Nijmegen), Tanya M. Bisseling(Radboud University Nijmegen), Ronald de Wit(Erasmus MC Cancer Institute), J. Martijn Kerst(The Netherlands Cancer Institute), Daniëlle Zweers(Utrecht University), Iris Lansdorp‐Vogelaar(Erasmus University Rotterdam), Beatriz Carvalho(Centro Universitário das Faculdades Metropolitanas Unidas), Anneke J. van Vuuren(Erasmus MC), Christina M. Robinson(Dartmouth–Hitchcock Medical Center), Sophia van Baalen(Erasmus MC), Pétur Snæbjörnsson(University of Iceland), Berbel L.M. Ykema(The Netherlands Cancer Institute), Inge L. Huibregtse, Britt B.M. Suelmann(University Medical Center Utrecht)
Cited by 1
Related Papers
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2017|1.3k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k
Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
|Endoscopy|2017|1.1k
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716